Regulation of Nef function

Research in Virology

Volumn 148, Issue 1, 1997, Pages 64-68

  Luo, T ^a   Garcia, J V ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; NEF PROTEIN; PROTEIN SERINE KINASE; THREONINE KINASE; UNCLASSIFIED DRUG;

CELL SURFACE; HUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; T LYMPHOCYTE ACTIVATION; VIRUS CELL INTERACTION; VIRUS INFECTIVITY;

EID: 0031053938     PISSN: 09232516     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2516(97)81916-4     Document Type: Conference Paper

References (27)

1. Aiken, C., Konner, J., Landau, N.R., Lenburg, M.E. & Trono, D. (1994), Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell, 76, 853-864.
2. Aiken, C. & Trono, D. (1995), Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol., 69, 5048-5056.
3. Anderson, S.J., Lenburg, M., Landau, N.R. & Garcia, J.V. (1994), The cytoplasmic domain of CD4 is sufficient for its downregulation from the cell surface by human immunodeficiency virus type 1 Nef. J. Virol., 68, 3092-3101.
4. Anderson, S.J., Shugars, D.C., Swanstrom, R. & Garcia, J.V. (1993), Nef from primary isolates of human immunodeficiency virus type 1 suppress surface CD4 expression in human and mouse T cells. J. Virol., 67, 4923-4931.
5. Baur, A.S., Sawai, E.T., Dazin, P., Fantl, W.J., Cheng-Mayer, C. & Peterlin, B.M. (1994), HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity, 1, 373-384.
6. Benaroch, P., Yilla, M., Raposo, G., Ito, K., Miwa, K., Geuza, H.J. & Ploegh, H.L. (1995), How MHC class II molecules reach the endocytic pathway. EMBO J. 14, 37-49.
7. Brady, H.J.M., Pennington, D.J., Miles, C.G. & Dzierzak, E.A. (1993), CD4 cell surface downregulation in HIV-1 Nef transgenic mice is a consequence of intracellular sequestration. EMBO J., 12, 4923-4932.
8. Bukrinskaya, A.G., Ghorpade, A., Heinzinger, N.K., Smithgall, T.E., Lewis, R.E. & Stevenson, M. (1996), Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. Proc. Natl. Acad. Sci. USA, 93, 367-371.
9. Deacon, N.J., Tsykin, A., Solomon, A., Smith, K., Ludford-Menting, M., Hooker, D.J., McPhee, D.A., Greenway, A.L., Ellett, A., Chatfield, C., Lawson, V.A., Crowe, S., Maerz, A., Sonza, S., Learmont, J., Sullivan, J.S., Cunningham, A., Dwyer, D., Dowton, D. & Mills, J. (1995), Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science, 270, 988-991.
10. Garcia, J.V., Alfano, J. & Miller, A.D. (1993), The negative factor of human immunodeficiency virus type 1 Nef on cell surface CD4 expression is not species-specific and requires the cytoplasmic domain of CD4. J. Virol., 67, 1511-1516.
11. Garcia, J.V. & Miller, A.D. (1991), Serine phosphorylation-independent downregulation of cell-surface CD4 by Nef. Nature (Lond.), 350, 508-511.
12. Goldsmith, M.A., Warmerdam, M.T., Atchison, R.E., Miller, M.D. & Green, W.C. (1995), Dissociation of the CD4 downregulation and virus infectivity enhancement functions of human immunodeficiency virus type 1 Nef. J. Virol., 69, 4112-4121.
13. Greenway, A., Azad, A. & McPhee, D. (1995), Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J. Virol., 69, 1842-1850.
14. Guy, B., Kieny, M.P., Rivière, Y., Peuch, C.L., Dott, K., Girard, M., Montagnier, L. & Lecocq, J.P. (1987), HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature (Lond.), 330, 266-269.
15. Guy, B., Rivière, Y., Kott, K., Regnault, A. & Kieny, M.P. (1990), Mutational analysis of the HIV Nef protein. Virology, 176, 413-425.
16. Harris, M.P. & Neil, J.C., (1994), Myristoylation-dependent binding of HIV-1 Nef to CD4. J. Mol. Biol., 241, 136-142.
17. Jamieson, B.D., Aldrovandi, G.M., Planelles, V., Jowett, J.B.M., Gao, L., Bloch, L.M., Chen, I.S.Y. & Zack, J.A. (1994), Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J. Virol., 68, 3478-3485.
18. Kestler, H.W., III, Ringler, D.J., Mori, K., Panicali, D.L., Sehgal, P.K., Daniel, M.D. & Desrosiers, R.C. (1991), Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell, 65, 651-662.
19. Lindemann, D., Wilhelm, R., Renard, P., Althage, A., Zinkernagel, R. & Mous, J. (1994), Severe immunodeficiency associated with a human immunodeficiency virus 1 NEF/3'-long terminal repeat transgene. J. Exp. Med., 179, 797-807.
20. Luo, T., Anderson, S.J. & Garcia, J.V. (1996), Inhibition of Nef-and phorbol ester-induced CD4 degradation by macrolide antibiotics. J. Virol, 70, 1527-1534.
21. Miller, M.D., Warmerdam, M.T., Page, K.A., Feinberg, M.B. & Greene, W.C. (1995), Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry. J. Virol., 69, 579-584.
22. Rhee, S.S. & Marsh, J.W. (1994), Human immunodeficiency virus type 1 nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. J. Virol., 68, 5156-5163.
23. Sawai, E.T., Baur, A.S., Strubel, H., Peterlin, B.M., Levy, J.A. & Cheng-Mayer, C. (1994), Human immunodeficiency virus type 1 nef associates with a cellular serine kinase in T lymphocytes. Proc. Natl. Acad. Sci. USA, 91, 1539-1543.
24. Sawai, E.T., Baur, A.S., Peterlin, B.M., Levy, J.A. & Cheng-Mayer, C. (1995), A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity. J. Biol. Chem., 270, 15307-15314.
25. Sawai, E.T., Khan, I.H., Cheng-Mayer, C. & Luciw, P.A. (1996), Association of Nef with a cellular protein kinase is important for pathogenesis in SIV-infected rhesus macaques. Abstract of Keystone Symposia. Taos, New Mexico.
26. Schwartz, O., Maréchal, V., Danos, O. & Heard, J.M. (1995), Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J. Virol., 69, 4053-4059.
27. Skowronski, J., Parks, D. & Mariani, R. (1993), Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO. J. 12, 703-713.